Clinical Research Directory

Inclusion Criteria: Participants who meet the following eligibility criteria will be selected from the registry: * Participants of 18 years of age or older at the time of infusion * Participants with a diagnosis of relapsed or refractory marginal zone lymphoma (R/R MZL) * Participants have received at least two prior lines of systemic therapy * Participants have been treated in the postmarketing setting with at least 1 infusion of lisocabtagene maraleucel: * used for the treatment of R/R MZL, * within the FDA-approved indication and dosage per the United States prescribing information and * product specifications approved for commercial release in the USA. * Participants have consented to share their data with the registry and the Sponsor. Exclusion Criteria: Participants who meet the following exclusion criterion will not be eligible for selection from the registry: • Participants known to be participating in investigational studies at the time of lisocabtagene maraleucel infusion.